SCHEMBL23925992

SCHEMBL23925992

COCc1n[nH]cc1C(=O)Cl

nearest known ligand 0.38

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 1/20 0.38
KDM5A P29375 1/20 0.33
KDM5B Q9UGL1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20524643 0.84 HCAR2 (0.46) HCAR2KDM5AKDM5B
SCHEMBL20524651 0.82 HCAR2 (0.38) HCAR2KDM5AKDM5B
SCHEMBL369544 0.82 NPC1 (0.39) HCAR2
Hydrochloric Acid SCHEMBL28435492 0.81 HCAR2 (0.37) HCAR2KDM5AKDM5B
SCHEMBL25289020 0.78 KMT2A (0.45)
Sulfuric Acid SCHEMBL28426836 0.77 HCAR2 (0.34) HCAR2KDM5AKDM5B
SCHEMBL16143800 0.74
SCHEMBL10665972 0.73 GAA (0.40) HCAR2
SCHEMBL15555947 0.72
SCHEMBL27804321 0.72 SRD5A2 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021211922-A1 SPIRO-SULFONIMIDAMIDE DERIVATIVES AS INHIBITORS OF MYELOID CELL LEUKEMIA-1 (MCL-1) PROTEIN PRELUDE THERAPEUTICS, INCORPORATED (US) 2021-10-21 WO disclosed